News

Goldman Sachs Boosts Barclays with Buy Rating Ahead of Growth

Goldman Sachs Boosts Barclays with Buy Rating Ahead of Growth

Goldman Sachs Initiates a Buy Rating for Barclays

Goldman Sachs has recently taken a favorable stance on Barclays Plc (NYSE: BCS), initiating coverage with a Buy rating and setting a price target of GBP2.90. This assessment follows a strong rally in Barclays' stock, which has seen a remarkable increase of over 40% year-to-date, significantly outperforming the banks index by 25 percentage points.

Valuation Analysis of Barclays Stock

Despite its impressive stock performance, Barclays is still trading at roughly 6 times its 12-month forward price-to-earnings (P/E) ratio. Goldman Sachs points out that this pricing represents a substantial discount when compared to both its historical averages and the European banking sector at large.

Future Earnings Potential

Goldman Sachs believes that the current valuation offers an attractive entry point for investors. They project Barclays to grow its earnings per share (EPS) at a rate twice that of its peers, predicting an average growth rate of 16% from 2024 to 2026, outpacing the 8% average expected for the broader group of banks under Goldman’s coverage.

Resilience Against Policy Changes

The firm also emphasizes Barclays' resilience in earnings, even in the event of a decline in policy rates. The UK's structural hedge is likely to support continued growth in the bank's Group Net Interest Income (NII), while its investment banking activities and US credit card sector are expected to benefit from possible reductions in interest rates.

Performance and Financial Results

Moreover, Goldman Sachs foresees that Barclays might outperform consensus estimates, with profit forecasts averaging 3% higher than the Visible Alpha Consensus Data for the 2024-26 period, grounded in what Goldman describes as cautious rate assumptions.

Recent Financial Achievements

In the context of recent financial achievements, Barclays reported its Q2 and H1 2024 results, reflecting progress aligned with its three-year strategic plan. The second quarter’s return on tangible equity (RoTE) reached 9.9%, approaching the bank's yearly target of over 10%. With total income for Q2 amounting to GBP 6.3 billion and net interest income projections around GBP 11 billion for the year, the financial outlook appears promising.

Shareholder Returns and Cost Management

Barclays also announced a total payout of GBP 1.2 billion for the first half of the year, which includes both dividends and a share buyback program. Looking ahead, the bank anticipates a structural hedge income upsurge of around $2 billion by 2026. Commitment to cost discipline shines through, as evidenced by GBP 0.4 billion in gross efficiency savings already achieved in H1.

Market Challenges and Strategic Goals

However, some skepticism lingers due to increased impairment in Q2 compared to the previous year and a decline in the net interest margin from 11.1% in Q1 to 10.4% in Q2. Barclays' executives noted the intricate nature of the ongoing sale of the merchant acquiring unit, with pending updates to be disclosed, reflecting a part of the bank's broader aim of maintaining flat risk-weighted assets (RWAs) in the investment banking segment while targeting growth in higher-return areas.

Market Context and Future Insights

Additional insights from the market reinforce Goldman Sachs' optimistic outlook on Barclays. The bank's P/E ratio is currently at 8.76, with an adjusted P/E of 7.31 for the last year, confirming the firm's perspective on Barclays' undervaluation. The stock has posted a striking total return of 60.63% year-to-date, with an even more impressive one-year return of 65.24%, making it a compelling case for investment.

Analysts' Upward Earnings Expectations

Analysts have recently adjusted their earnings forecasts for Barclays upwards, aligning with Goldman’s expectations of potential outperformance against consensus estimates. Investors looking for a comprehensive understanding of Barclays' financial health can access numerous insights highlighting its robust liquidity position, likely contributing to the expected earnings resilience amidst changing policy landscapes.

Frequently Asked Questions

Why did Goldman Sachs initiate a Buy rating for Barclays?

Goldman Sachs initiated a Buy rating based on Barclays' strong performance and growth potential, coupled with its current discounted valuation.

What is Barclays' price target set by Goldman Sachs?

The price target set for Barclays by Goldman Sachs is GBP2.90.

How much has Barclays' stock increased year-to-date?

Barclays' stock has risen over 40% year-to-date, outperforming the banks index significantly.

What is the projected growth rate for Barclays' EPS?

Goldman Sachs projects Barclays' EPS to grow at 16% from 2024 to 2026, nearly double that of its peers.

What recent financial results did Barclays report?

Barclays reported a Q2 RoTE of 9.9%, with total income for the quarter at GBP 6.3 billion and net interest income expected around GBP 11 billion for the year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 9

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 6

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 6

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Amalgamated Financial's Upcoming Earnings Report

Updated Category News Views 81

Understanding Amalgamated Financial's Earnings Outlook As Amalgamated Financial (NASDAQ: AMAL) approaches the announcement of its quarterly earnings, investors are buzzing with enthusiasm and anticipation. The report is set for October 24, and the financial community is eager to see how the company's performance aligns with market expectations. Analysts project the...

Continue Reading
Aquiline Completes Acquisition of Archway to Boost Innovation

Updated Category News Views 370

Aquiline Completes Acquisition of Archway Aquiline, a private investment firm specializing in financial services and technology, has officially closed its acquisition of SEI's Family Office Services business, which will now operate under the original name, Archway. This strategic move marks an exciting opportunity for both Aquiline and Archway to enhance their offerings...

Continue Reading
Hone Health Raises $33 Million to Enhance Telehealth Services

Updated Category News Views 946

Hone Health Completes $33 Million Series A Funding Hone Health, a leading name in telehealth focused on preventative and proactive longevity care, has achieved a significant milestone by securing $33 million in a Series A funding round. This funding was supported by notable investors such as Tribe Capital, PIF, Republic Capital, and others, raising the total funding for...

Continue Reading
Opportunity for NEM Investors to Participate in Lawsuit

Updated Category News Views 141

Understanding the Newmont Corporation Lawsuit Investors in Newmont Corporation (NYSE: NEM) are presented with a significant opportunity to engage in a class action lawsuit. This action was initiated by a shareholder who aims to represent others who purchased securities of Newmont between a defined period. A class action lawsuit has already been filed, and interested...

Continue Reading
Long-Term Trust in Primary Care Linked to Fewer Hospital Visits

Updated Category News Views 140

Importance of Long-Term Primary Care Relationships Long-term relationships between patients and primary care physicians play a pivotal role in healthcare delivery. Recent studies published in the Annals of Family Medicine emphasize the importance of these relationships, revealing insights that could transform patient care. One significant study links the consistency of...

Continue Reading